Introduction
All you need to know about LUKRA 4mg .
Welcome to Dwaey, specifically on LUKRA 4mg page.
This medicine contains an important and useful components, as it consists of Montelukast (as sodium).
LUKRA 4mg is available in the market in concentration 4mg/Tablet and in the form of Tablets/Chewable.
NEOPHARMA is the producer of LUKRA 4mg and it is imported from UAE, The most popular alternatives of LUKRA 4mg are listed downward .
-
Active Substance
Montelukast (as sodium)
-
Size
30 s (10 s Blister x 3)
-
Indications
-
Type
Tablets/Chewable
-
Company
NEOPHARMA
Frequently Asked Questions
LUKRA 4mg should be stored according to the instructions provided by NEOPHARMA.
In general, it is recommended to store LUKRA 4mg in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with LUKRA 4mg may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking LUKRA 4mg for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking LUKRA 4mg. Some medications, including
LUKRA 4mg, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of LUKRA 4mg, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking LUKRA 4mg without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking LUKRA 4mg if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of LUKRA 4mg during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 4mg/Tablet,
and the specific recommendations of NEOPHARMA.
The effects of LUKRA 4mg on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 4mg/Tablet, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking LUKRA 4mg with or without food may vary depending on the medication
and the recommendations of NEOPHARMA. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of LUKRA 4mg in children or elderly individuals may depend on various factors, including
the specific medication, type Tablets/Chewable, and the recommendations of NEOPHARMA. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of LUKRA 4mg in children or elderly individuals.
0 Comments